randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als The Scientific and Therapeutic Rationale Off‐Label Treatments in Amyotrophic Lateral Sclerosis - Bedlack - 2025 - Annals Neurology Erythropoietin in amyotrophic lateral sclerosis:

Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study Journal of Neurology, Neurosurgery & Psychiatry A multicenter, randomized, placebo controlled, double blind phase 3 trial with open arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport's syndrome Kidney International Efficacy and safety of low dose IL 2 as an add on therapy to riluzole (MIROCALS): a phase 2b, double blind, randomised, placebo controlled trial The Lancet In the randomized, double blind, placebo controlled, global Phase III trial recently presented in the ASCO 2024 annual meeting, consolidation treatment with #durvalumab significantly improved clinical outcomes for patients with limited stage small cell

SKU: 48066282260 · From webdevsolutions.tech